Document Preview Unavailable
Fibroblast growth factor 21 is associated with increased serum total antioxidant capacity and oxidized lipoproteins in humans with different stages of chronic kidney disease
Gómez-Sámano, Miguel Ángel; Vargas-Abonce, Valerie Paola; Martínez-Sánchez, Froylan David; Palacios-Báez Lucía; Vera-Zertuche, Juan Mauricio; et al. Therapeutic Advances in Endocrinology and Metabolism Vol. 12, (Jan 2021).You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library